Vor is a rapidly scaling company that is tackling autoimmune disease at its root by working on a first- and potentially best-in-class dual BAFF/APRIL inhibitor.
Join Vor, a rapidly scaling company, in tackling autoimmune disease at its root by working on a first- and potentially best-in-class dual BAFF/APRIL inhibitor. Contribute to a medicine with best-in-disease Phase 3 results in myasthenia gravis and expansion into multiple autoimmune diseases.
Vor is a rapidly scaling company that is tackling autoimmune disease at its root by working on a first- and potentially best-in-class dual BAFF/APRIL inhibitor.
Vor Bio